Pacira BioSciences' Shares Outstanding (Weighted Average) fell 218.72% to $45.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.3 million, marking a year-over-year decrease of 218.72%. This contributed to the annual value of $46.2 million for FY2024, which is 4.98% up from last year.
Pacira BioSciences' Shares Outstanding (Weighted Average) amounted to $45.3 million in Q3 2025, which was down 218.72% from $45.9 million recorded in Q2 2025.
Pacira BioSciences' Shares Outstanding (Weighted Average)'s 5-year high stood at $46.5 million during Q1 2024, with a 5-year trough of $43.8 million in Q1 2021.
Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $45.9 million (2025), whereas its average is $45.6 million.
As far as peak fluctuations go, Pacira BioSciences' Shares Outstanding (Weighted Average) surged by 455.7% in 2021, and later crashed by 218.72% in 2025.
Pacira BioSciences' Shares Outstanding (Weighted Average) (Quarter) stood at $44.3 million in 2021, then increased by 2.84% to $45.5 million in 2022, then grew by 1.54% to $46.2 million in 2023, then increased by 0.05% to $46.2 million in 2024, then dropped by 2.14% to $45.3 million in 2025.
Its Shares Outstanding (Weighted Average) stands at $45.3 million for Q3 2025, versus $45.9 million for Q2 2025 and $46.3 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value